Logo image of CLSK

CLEANSPARK INC (CLSK) Stock Fundamental Analysis

USA - NASDAQ:CLSK - US18452B2097 - Common Stock

19.525 USD
-0.46 (-2.33%)
Last: 10/17/2025, 8:03:32 PM
19.8486 USD
+0.32 (+1.66%)
After Hours: 10/17/2025, 8:03:32 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CLSK. CLSK was compared to 283 industry peers in the Software industry. CLSK scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CLSK is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

CLSK had positive earnings in the past year.
In the past year CLSK has reported a negative cash flow from operations.
CLSK had negative earnings in each of the past 5 years.
CLSK had negative operating cash flow in 4 of the past 5 years.
CLSK Yearly Net Income VS EBIT VS OCF VS FCFCLSK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M -300M

1.2 Ratios

Looking at the Return On Assets, with a value of 9.43%, CLSK belongs to the top of the industry, outperforming 84.51% of the companies in the same industry.
CLSK has a Return On Equity of 13.62%. This is in the better half of the industry: CLSK outperforms 79.93% of its industry peers.
Industry RankSector Rank
ROA 9.43%
ROE 13.62%
ROIC N/A
ROA(3y)-12.83%
ROA(5y)-29.98%
ROE(3y)-14.38%
ROE(5y)-38.48%
ROIC(3y)N/A
ROIC(5y)N/A
CLSK Yearly ROA, ROE, ROICCLSK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

CLSK has a Profit Margin of 46.28%. This is amongst the best in the industry. CLSK outperforms 94.37% of its industry peers.
With a Gross Margin value of 52.05%, CLSK is not doing good in the industry: 66.20% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of CLSK has grown nicely.
Industry RankSector Rank
OM N/A
PM (TTM) 46.28%
GM 52.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.33%
GM growth 5Y29.35%
CLSK Yearly Profit, Operating, Gross MarginsCLSK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

More info and screens

5

2. Health

2.1 Basic Checks

CLSK does not have a ROIC to compare to the WACC, probably because it is not profitable.
CLSK has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CLSK has been increased compared to 5 years ago.
The debt/assets ratio for CLSK is higher compared to a year ago.
CLSK Yearly Shares OutstandingCLSK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
CLSK Yearly Total Debt VS Total AssetsCLSK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 3.85 indicates that CLSK is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.85, CLSK is doing good in the industry, outperforming 64.08% of the companies in the same industry.
CLSK has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
CLSK has a Debt to Equity ratio (0.30) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z 3.85
ROIC/WACCN/A
WACC11.21%
CLSK Yearly LT Debt VS Equity VS FCFCLSK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 4.37 indicates that CLSK has no problem at all paying its short term obligations.
With an excellent Current ratio value of 4.37, CLSK belongs to the best of the industry, outperforming 85.56% of the companies in the same industry.
A Quick Ratio of 4.37 indicates that CLSK has no problem at all paying its short term obligations.
The Quick ratio of CLSK (4.37) is better than 85.56% of its industry peers.
Industry RankSector Rank
Current Ratio 4.37
Quick Ratio 4.37
CLSK Yearly Current Assets VS Current LiabilitesCLSK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

8

3. Growth

3.1 Past

CLSK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 334.48%, which is quite impressive.
The Revenue has grown by 84.66% in the past year. This is a very strong growth!
The Revenue has been growing by 142.70% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)334.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%485%
Revenue 1Y (TTM)84.66%
Revenue growth 3Y112.85%
Revenue growth 5Y142.7%
Sales Q2Q%90.81%

3.2 Future

CLSK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 176.49% yearly.
Based on estimates for the next years, CLSK will show a very strong growth in Revenue. The Revenue will grow by 47.44% on average per year.
EPS Next Y1901.58%
EPS Next 2Y308.08%
EPS Next 3Y176.49%
EPS Next 5YN/A
Revenue Next Year97.11%
Revenue Next 2Y68.31%
Revenue Next 3Y47.44%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CLSK Yearly Revenue VS EstimatesCLSK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
CLSK Yearly EPS VS EstimatesCLSK Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 28.71, which means the current valuation is very expensive for CLSK.
67.25% of the companies in the same industry are more expensive than CLSK, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.40, CLSK is valued at the same level.
CLSK is valuated correctly with a Price/Forward Earnings ratio of 16.75.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CLSK indicates a somewhat cheap valuation: CLSK is cheaper than 79.58% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.94, CLSK is valued a bit cheaper.
Industry RankSector Rank
PE 28.71
Fwd PE 16.75
CLSK Price Earnings VS Forward Price EarningsCLSK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CLSK is valued a bit cheaper than the industry average as 71.83% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 33.39
CLSK Per share dataCLSK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CLSK's earnings are expected to grow with 176.49% in the coming years.
PEG (NY)0.02
PEG (5Y)N/A
EPS Next 2Y308.08%
EPS Next 3Y176.49%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CLSK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CLEANSPARK INC

NASDAQ:CLSK (10/17/2025, 8:03:32 PM)

After market: 19.8486 +0.32 (+1.66%)

19.525

-0.46 (-2.33%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)12-01 2025-12-01/amc
Inst Owners64.03%
Inst Owner Change0.11%
Ins Owners1.49%
Ins Owner Change74.81%
Market Cap5.49B
Analysts82.11
Price Target21.95 (12.42%)
Short Float %20.42%
Short Ratio2.39
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.02
Dividend Growth(5Y)N/A
DP1.76%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-116.33%
Min EPS beat(2)-403.92%
Max EPS beat(2)171.26%
EPS beat(4)2
Avg EPS beat(4)-45.39%
Min EPS beat(4)-403.92%
Max EPS beat(4)171.26%
EPS beat(8)4
Avg EPS beat(8)44.86%
EPS beat(12)7
Avg EPS beat(12)30.55%
EPS beat(16)7
Avg EPS beat(16)-12.58%
Revenue beat(2)1
Avg Revenue beat(2)-3.44%
Min Revenue beat(2)-7.4%
Max Revenue beat(2)0.51%
Revenue beat(4)2
Avg Revenue beat(4)-0.86%
Min Revenue beat(4)-7.4%
Max Revenue beat(4)4.69%
Revenue beat(8)4
Avg Revenue beat(8)-0.74%
Revenue beat(12)5
Avg Revenue beat(12)-1.54%
Revenue beat(16)5
Avg Revenue beat(16)-4%
PT rev (1m)0%
PT rev (3m)6.95%
EPS NQ rev (1m)11.52%
EPS NQ rev (3m)227.36%
EPS NY rev (1m)32.19%
EPS NY rev (3m)97.98%
Revenue NQ rev (1m)-2.13%
Revenue NQ rev (3m)5.07%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)3.66%
Valuation
Industry RankSector Rank
PE 28.71
Fwd PE 16.75
P/S 8.68
P/FCF N/A
P/OCF N/A
P/B 2.56
P/tB 2.73
EV/EBITDA 33.39
EPS(TTM)0.68
EY3.48%
EPS(NY)1.17
Fwd EY5.97%
FCF(TTM)-2.25
FCFYN/A
OCF(TTM)-1.51
OCFYN/A
SpS2.25
BVpS7.64
TBVpS7.15
PEG (NY)0.02
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.43%
ROE 13.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 46.28%
GM 52.05%
FCFM N/A
ROA(3y)-12.83%
ROA(5y)-29.98%
ROE(3y)-14.38%
ROE(5y)-38.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.33%
GM growth 5Y29.35%
F-Score2
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA 3.43
Cap/Depr 71.17%
Cap/Sales 32.87%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.37
Quick Ratio 4.37
Altman-Z 3.85
F-Score2
WACC11.21%
ROIC/WACCN/A
Cap/Depr(3y)65.93%
Cap/Depr(5y)337.91%
Cap/Sales(3y)31.8%
Cap/Sales(5y)89.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)334.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%485%
EPS Next Y1901.58%
EPS Next 2Y308.08%
EPS Next 3Y176.49%
EPS Next 5YN/A
Revenue 1Y (TTM)84.66%
Revenue growth 3Y112.85%
Revenue growth 5Y142.7%
Sales Q2Q%90.81%
Revenue Next Year97.11%
Revenue Next 2Y68.31%
Revenue Next 3Y47.44%
Revenue Next 5YN/A
EBIT growth 1Y-73.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1190.56%
EBIT Next 3Y139.07%
EBIT Next 5YN/A
FCF growth 1Y-60294%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1405.16%
OCF growth 3YN/A
OCF growth 5YN/A